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A cost analysis of implementation of interventions informs budgeting and economic
evaluations.
Objective
To estimate the cost of implementing the integrated chronic disease management (ICDM)
model in primary healthcare (PHC) clinics in South Africa.
Methods
Cost data from the provider’s perspective were collected in 2019 from four PHC clinics with
comparable patient caseloads (except for one). We estimated the costs of implementing the
ICDM model current activities for three (facility reorganization, clinical supportive manage-
ment and assisted self-management) components and additional costs of implementing
with enhanced fidelity. Costs were estimated based on budget reviews, interviews with man-
agement teams, and other published data. The standard of care activities such as medica-
tion were not included in the costing. One-way sensitivity analyses were carried out for key
parameters by varying patient caseloads, required infrastructure and staff. Annual ICDM
model implementation costs per PHC clinic and per patient per visit are presented in 2019
US dollars.
Results
The overall mean annual cost of implementing the ICDM model was $148 446.00 (SD: $65
125.00) per clinic. Current ICDM model activities cost accounted for 84% ($124 345.00) of
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the annual mean cost, while additional costs for higher fidelity were 16% ($24 102.00). The
mean cost per patient per visit was $6.00 (SD:$0.77); $4.94 (SD:0.70) for current cost and
$1.06 (SD:0.33) for additional cost to enhance ICDM model fidelity. For the additional cost,
49% was for facility reorganization, 31% for adherence clubs and 20% for training of nursing
staff. In the sensitivity analyses, the major cost drivers were the proportion of effort of assis-
ted self-management staff and the number of patients with chronic diseases receiving care
at the clinic.
Conclusion
Minimal additional cost are required to implement the ICDM model with higher fidelity. Fur-
ther research on the cost-effectiveness of the ICDM model in middle-income countries is
required.
Background
Chronic diseases are a major public health challenge, accounting for 60% of all deaths, with
35% and 40% of deaths due to chronic diseases occurring in low and middle income countries
respectively [1–3]. Chronic diseases can cost up to 7% of a country’s gross domestic product
(GDP) due to the undesirable effect these diseases have on economic activities and increased
public health and social welfare expenditure [3, 4]. In high-income settings such as the USA,
Europe and Spain, the cost of the increasing number of chronic illnesses account for 75%, 80%
and 77% of the total healthcare cost respectively [5, 6]. The key drivers of cost in health systems
are increased utilization of services, medication and health system adaptation of service deliv-
ery [3].
South Africa, like many low and middle-income countries, has a dual burden of chronic
diseases, with a high prevalence of both communicable and non-communicable chronic dis-
eases [7, 8]. Data from Free State Province indicate that 24% of the population suffer from
chronic diseases [9]. Results from a Cape Town study showed that prevalence of multi-mor-
bidity is approximately 23%, and chronic diseases account for 45% of all primary healthcare
(PHC) consultations [10]. Nevertheless, the diagnostic tools, training and supervision of clini-
cal staff as they manage and provide care for chronic conditions are inadequate, particularly at
the PHC level [11, 12]. In an effort to address this challenge, the South African Department of
Health developed and implemented the integrated chronic disease management (ICDM)
model [13]. The ICDM model was developed based on the principles of the chronic care
model (CCM) and innovative care for chronic conditions (ICCC) framework [13, 14].
Research in other settings has indicated that integrated chronic care models improve patient
care and health outcomes [15–17].
The aim of the ICDM model is to provide a comprehensive chronic disease management
model that reduces healthcare utilization and promotes self-management among patients with
chronic diseases [13, 14]. Patients who are incorporated into the ICDM model include adults
and children with chronic communicable (HIV/AIDS and tuberculosis) and non-communica-
ble (hypertension, diabetes, asthma, chronic obstructive pulmonary disease, mental health and
epilepsy) diseases [13]. The ICDM model consists of four inter-related components, namely
facility reorganization, clinical supportive management, assisted self-management and
strengthening of support systems [13, 14].
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Facility reorganization activities include management of patient flow, bookings and records
to enhance clinic operational effeciency [13]. Clinical supportive management includes the
activities of the district clinical specialist team (DCST) and the training of nurses on primary
healthcare and management of the conditions included in the ICDM model [13]. Assisted self-
management activities aim to empower patients to become involved in their disease manage-
ment and be supported at community level [13]. Community level support is provided by
ward-based outreach teams (WBOTs) and community healthcare workers (CHCW). Patients
with chronic conditions who are stable on treatment are offered the option of collecting pre-
packed medication at the PHC clinic or at other outlets under the central chronic medicine
dispensing and distribution (CCMDD) programme [13]. The strengthening of support sys-
tems promotes collaborations between the clinic and other departments like school health and
support structures for health services delivery such as community organizations [13]. An
assessment of the ICDM model implementation has shown enhancements in patients’ records,
improved health outcomes for HIV-positive patients on antiretroviral medication, but no sub-
stantial improvements for patients with hypertension [18, 19].
Developing, implementing and evaluating effectiveness and implementation outcomes are
essential in public healthcare research [20]. The implementation outcomes or measures of suc-
cessful implementation an intervention or a programme, include amongst others, fidelity,
implementation costs, acceptability and sustainability [21]. Implementation costs of interven-
tions reveals the feasibility, scalability and sustainability of proposed integrated care interven-
tions [20]. Implementation costs is one of the implementation outcomes that also allows
decision makers to determine and choose which interventions are efficient and equitable [20].
Fidelity is the degree to which the implementation of a programme follows the original design
as outlined in the guidelines [22, 23]. A process evaluation of the implementation fidelity of
the ICDM model indicates that the level of fidelity (adherence) to guidelines varies between
clinics, with some clinics having high scores (80%-89%), and others having medium (70%-
79%) and low (<70%) scores [24]. Chronic care models are also cost-effective as they reduce
healthcare services utilization and improved disease management [15–17]. However, there are
no data on the cost of implementing the ICDM model in South Africa. The objective of this
study was to estimate the empirical implementation cost of each of the components of the
ICDM model in two health districts to inform planning, scaling-up and further economic eval-
uations. In addition, we assessed if the degree of fidelity to the ICDM model guidelines has an
impact on the cost of implementing the ICDM model.
Methods
Overview
This analysis is nested within a larger study to assess the level and determinants of fidelity in
the implementation of the ICDM model in the two health districts in South Africa [25]. We
evaluated the cost of implementing three (facility reorganization, clinical supportive manage-
ment, assisted self-management) of the four components of the ICDM model from the health
system perspective. The strengthening of support systems was not included in the cost analysis
as the activities are extensive and most of the costs are covered by collaborating organizations.
In addition to evaluating the current cost of operating the ICDM model, we estimated the cost-
ing of the additional activities or infrastructure required to implement the ICDM model with a
high degree of fidelity in a PHC clinic per annum. Due to lack of data on the ICDM model’s
effectiveness in optimizing clinical outcomes, we conducted a cost analysis using the empirical
micro-costing. Standard healthcare service costs like medication, laboratory investigations and
management of complications were excluded from the analysis to keep the focus on the ICDM
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model activities. The standard costs would be incurred irrespective of the ICDM model and
their inclusion would overestimate the costs of the ICDM model activities.
The setting
The study was conducted in two health districts in South Africa, the West Rand (WR) district
in the Gauteng province and the Dr. Kenneth Kaunda (DKK) district in the North West prov-
ince [25]. These two health districts, as well as Bushbuckridge health district in Mpumalanga,
were the pilot sites for implementing the ICDM model in South Africa on the initiative the
South African National Department of Health in 2011 [26]. The two health districts were
selected for this study as they have comparable population sizes and burden of disease. The
population sizes in the two districts are similar (811 000 in WR and 716 000 in DKK health dis-
trict) [27]. In 2011, the provincial HIV prevalence was also comparable (12.4% and 13.3% in
Gauteng and North West, respectively [28]). Hypertension prevalence is high (31%- 39.7%) in
both health districts, with high health service utilization for chronic non-communicable dis-
eases [27]. In Gauteng, 63% of the households rely on state health facilities (clinics and hospi-
tals) for health services, while 73% of the households in North West depend on state health
facilities [29]. We selected these two districts as the ICDM model had been implemented in
these districts for over 7 years. The cost analysis would therefore be representative of medium
to long-term scale-up scenarios.
Ethics approval
The study was approved by the ethics committees of the University of Cape Town (Ref: 127/
2018) and the University of the Witwatersrand (Ref: R14/49).
Data collection
Clinic selection. Four of the 16 PHC clinics that formed part of the larger ‘degree of fidel-
ity’ study [25] were selected based on their ICDM model implementation fidelity scores and
patient caseloads. One of the clinics with the highest [clinics A (87.%) and B (84.8%)] fidelity
scores and one of the clinics with the lowest [clinics C (76.6%) and D(65.8%)] fidelity scores
[24]. were chosen per health district for the cost analysis. The four clinics had comparable
characteristics (personnel and patient consultations) as summarized in Table 1. However,
clinic A had more consulting rooms and fewer patients consulting for chronic diseases
management.
Estimation of costs. Costs were stated according to the 2019 prices and converted to US
dollars (US$) at an exchange rate of ZAR 14.42 equal to US$ 1 [30]. The costs are reported as
annual costs per PHC clinic and per patient with chronic disease per visit. The current cost
and the additional cost of required infrastructure or unexecuted recommended ICDM model
activities were estimated as outlined below.
Facility reorganization cost. The current costs were estimated based on interviews with
key personnel, budget reviews and estimating the proportion of resources allocated to patients
with chronic disease based on the clinic consultations records. On average, 59% of the patients
attending the four PHC clinics were consulting for chronic disease care. Therefore, we used
this proportion to apportion facility reorganization costs for the current activities. Items
included in the cost estimate for current facility reorganization were building (reception, wait-
ing areas, vital signs station and consulting rooms), equipment and furniture, and building
maintenance costs. Additional infrastructure cost for facility reorganization were based on the
estimates according to the guidelines, as well as current cost. The ICDM model guidelines rec-
ommend that patients with chronic diseases should have separate waiting rooms, a vital signs
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station and consultation rooms. On evaluation of the fidelity and patient flow analysis, some
clinics did not meet the guidelines for adequate infrastructure. Therefore, the additional facil-
ity reorganization cost was calculated by calculating the cost of building an additional three
consultation rooms for clinics C and D only, as clinics A and B had adequate consultation
rooms according to the guidelines. Furthermore, additional facility reorganization costs
included building a waiting area, a vital signs station, a CCMDD kiosk and a multi-purpose
meeting room for adherence clubs meetings for each of the four clinics. The South African
building cost of US$ 561.17 per m2 was used to estimate the cost of building the additional
Table 1. Characteristics of the primary healthcare clinics included in the cost analysis of implementing the Integrated Chronic Disease Management (ICDM)
model.
Variable Clinic A Clinic B Clinic C Clinic D
Fidelity to the ICDM model Score (Percentage)
Overall fidelity of the ICDM model implementation 136/158 (87.3) 134/158 (84.8) 121/158 (76.6) 104/158 (65.8)
Facility reorganization 29/37 (78.4) 27/37 (73.0) 30/37 (81.1) 29/37 (78.4)
Clinical supportive management 37/39 (94.9) 33/39 (84.6) 29/39 (74.4) 20/39 (51.3)
Assisted self-management 36/39 (92.3) 37/39 (94.9) 27/39 (69.2) 30/39 (76.9)
Strengthening of support systems 34/43 (79.1) 37/43 (86.1) 35/43 (81.4) 25/43 (58.1)
Number of Personnel
Professional nurses 4 5 6 10
Enrolled nurses 3 0 5 1
Medical officers 1 1 5 1
Pharmacists assistant 0 0 1 0
Administrative staff 5 8 3 1
Counsellors 2 6 4 7
WBOT^ Leaders 4 2 4 2
WBOT^/CHCW# 4 13 50 17
Nurse patient ratio 333 731 370 340
Medical officer patient ratio 2328 3655 814 3735
Patient consultations per month. per facility mean (SD)
Total primary healthcare headcount 2328 (150) 3655 (206) 4068 (146) 3735 (245)
Total patients >20 years per month per facility 1530 (126) 2457 (187) 2865 (106) 2795 (233)
Total patients with chronic diseases consultations� 981 (67) 2653 (133) 2922 (302) 1802 (144)
Proportion of patients with chronic diseases consultation to total headcount 42% 73% 72% 48%
Adults in care for HIV/AIDS 687 (38) 2240 (27) 2004 (48) 1434 (13)
New TB diagnosis 2 (1) 4 (5) 3 (1) 14 (3)
Diabetic patients consultation 63 (8) 90 (24) 144 (30) 57 (4)
Hypertensive patients consultations 243 (34) 344 (119) 768 (157) 227 (126)
Nurse patient ratio 259 406 452 414
Infrastructure
Total area in m2 557 1367 491 442
Number of consulting rooms 8 5 2 3
Vital signs stations 1 1 1 1
Waiting areas 2 1 1 2
Reception/Medical Reocords 1 1 1 1
^WBOT–Ward-based outreach teams
#CHCW–Community healthcare worker
�Based on the number of patients with each disease. and not taking into consideration multi-morbidity
https://doi.org/10.1371/journal.pone.0235429.t001
PLOS ONE Implementation cost of the ICDM model
PLOS ONE | https://doi.org/10.1371/journal.pone.0235429 June 26, 2020 5 / 15
recommended areas based on valued office building costs [31]. The size of the rooms, furniture
and equipment requirements were based on the data collected and the guideline recommenda-
tions [32, 33]. The cost of the equipment and furniture were sourced from large furniture and
medical supplies stores. A discount rate of 7% [34] was applied to calculate the annual cost of
buildings, furniture and equipment with an estimated life span of 20 years, 10 years and 5
years respectively.
Clinical supportive management cost. The current cost of clinical supportive manage-
ment were calculated based on costs of the DCST providing support to each PHC in the dis-
trict. The DCST in the DKK district did not provide support to PHC clinics on management
of patients with chronic diseases, so the cost of providing the DCST in the WR district was
used for the DKK district. The proportion of time apportioned to patients with chronic dis-
eases was determined by interviewing the DCST leader in the WR health district. The propor-
tion allocation of personnel (family physician, senior pediatric medical officer, pediatric nurse
and senior PHC nurse) costs and telecommunication costs for the DCST to ICDM model was
calculated and divided by number of clinics in each health district. The additional cost of clini-
cal supportive management was for training nurses on PHC- and nurse-initiated management
of antiretroviral treatment (NIMART) [13]. The training cost was obtained from a training
organization that delivers the two training courses on behalf of the Department of Health. We
worked on the assumption that all professional nurses at the clinics would have to be trained
to account for staff turn-over. Travel cost was not included as the training is usually delivered
in the district.
Assisted self-management cost. The current costs of CHCW, WBOT and supervision
was estimated according the current salaries and the proportion of time allocated by the staff
members to support patients with chronic diseases. Staff salary values were informed by the
National Department of Health salary scales. All four of the PHC clinics had no functional
adherence clubs, thus the additional cost of training staff on adherence support and ongoing
provision of the adherence clubs was sourced from the literature [35]. Data on adherence
clubs’ cost were only available for 2011 [35], and the average inflation of 5.4% was applied to
estimate the costs for 2019.
Sensitivity analysis. One-way sensitivity analyses were performed on all cost estimates
that were major (> 4%) components of the cost for both current and additional costs. We var-
ied the discount rate from 4% to 9% (based on data for the last 5 years [34]) to assess the differ-
ent scenarios of cost for current and additional building costs. In addition, under the current
cost, building and building maintenance were varied for the proportion of patients that consult
for chronic disease using one standard deviation of the mean of 59% as this was applied in the
initial analysis. For the additional costs, building cost was varied depending on whether addi-
tional consulting rooms are required. One standard deviation (SD) was applied to calculate the
highest and lowest cost for WBOTs and WBOT supervision from the mean effort of 62% and
52% respectively. The mean number of patients and the SD were used in the sensitivity analy-
ses for the adherence club cost. The SD of the numbers of nurses that have to be trained was
applied for the NIMART and PHC training sensitivity analysis.
Results
Implementation cost of the ICDM model
The overall ICDM model implementation cost. Based on the data collected from the
four PHC clinics, the annual cost (current and additional costs) of implementing the ICDM
model per PHC clinic varied from $77 726.00 in clinic A to $232 103.00 in clinic C (Table 2).
The mean overall annual cost of implementing the recommended activities of the ICDM
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model per facility was $148 447.00 (SD: $65 125.00), and the mean cost per patient per visit
was $6.00 (SD:$0.77). Capital costs were 24% ($35 760.09) of the total annual mean costs. Cur-
rent cost contributed 84% ($124 345.00) of the total annual mean cost, while additional cost
accounted for 16% ($24 102.00) (Table 3). Almost two-thirds of the current cost came from
the personnel cost of the WBOTs/CHCW and their supervision under assisted self-manage-
ment (66%; $91 204.00). For the additional annual cost, facility reorganization accounted for
49% ($9 668.64), while adherence clubs and the training cost for nurses were 31% ($7 470.80)
and 20% ($4 868.60) respectively. The additional recurrent costs to achieve higher ICDM
model fidelity per patient per visit was $0.62 (SD: 0.15).
In all of the four PHC clinics, the current cost was higher than the additional (infrastruc-
ture, training and adherence clubs) cost required to enhance the degree of fidelity. The cost
per patient per visit for each of the four clinics for the current cost ranged from $4.30 to $5.79
(mean: $4.94; SD:0.70) and the additional cost from $0.72 to $1.37 (mean: $1.06; SD:0.33). The
clinics with the higher level of ICDM model implementation fidelity had a lower additional
annual cost [clinic A ($16,081) and clinic B($22,838)], compared to those with lower degree of
fidelity [clinic C ($29,188) and clinic D (28,299)].
Facility reorganization. The mean cost of facility reorganization contributed 25.8% ($32
021.79) to the current annual cost and 49% ($9 668.64) to the additional annual cost. The
building costs for clinic B are higher compared to the other clinics as it is based in a large
repurposed manucipality building. These additional facility reorganization cost included the
capital investment of building additional facilities dedicated for chronic patients, such as a
vital signs station, a waiting area, a CCMDD kiosk and a multi-purpose room in all four clin-
ics, as well as three consulting rooms in two of the clinics. The cost of maintaining the
Table 2. The estimated annual current and additional costs to enhance the fidelity to the ICDM model recommended activities in the four study clinics–A and B
high fidelity, C moderate and D low fidelity.
ICDM Model Component Items Clinic A Clinic B Clinic C Clinic D
Current Costs Facility reorganization Building $12 432.88 $52 559.23 $18 681.49 $11 321.36
Furniture $1 580.38 $2 162.55 $1 726.56 $1 346.59
Equipment $746.67 $ 867.02 $443.22 $390.56
Building maintenance $ 3 118.68 $13 184.02 $4 686.08 $2 839.86
Clinical supportive management DCST $1 019.93 $1 218.25 $1 019.93 $1 218.25
Assisted self-management WBOT Supervision $31 128.78 $29 288.06 $31 128.78 $29 288.06
WBOT $ 11 618.26 $37 759.34 $145 228.22 $49 377.59
Total current costs $61 645.58 $137 038.46 $202 914.28 $ 95 782.28
Additional Costs to enhance Fidelity Facility reorganization Building $ 7 395.30 $7 395.30 $9 296.95 $9 296.95
Furniture $150.46 $150.46 $1 630.84 $1 630.84
Equipment $56.45 $56.45 $807.28 $ 807.28
Building maintenance $1 855.05 $1 855.05 $2 332.06 $2 332.06
Clinical supportive management NIMART Training $1 715.08 $ 2 143.85 $2 572.61 $ 4 287.69
PHC Training $1 400.83 $1 751.04 $2 101.24 $3 502.07
Assisted self-management Adherence Club $3 507.47 $9 485.54 $10 447.32 $6 442.87
Total additional costs $16 081 $22 838 $29 188 $28 300
Estimated total costs of implementing ICDM model in each PHC clinic (Current costs + additional
costs to enhance fidelity)
$77 726.21 $159 876.14 $232 102.59 $124 082.04
Costs per patient per visit
Current costs per patient per visit $5.24 $4.30 $5.79 $4.43
Additional costs per patient per visit $1.37 $0.72 $0.83 $1.31
Total mean costs per patient per visit $6.60 $5.02 $6.62 $5.74
https://doi.org/10.1371/journal.pone.0235429.t002
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additional spaces, for instance ensuring cleanliness, water and sanitation was estimated at $2
093.55 per annum. The mean cost of equipment and furniture was estimated at $1 322.52 per
annum.
Clinical supportive management. Clinical supportive management activities accounted
for 0.9% ($1 119.09) of the total current annual cost of implementing the ICDM model. The
mean cost of the DCST providing support to each health facility was low as the proportion of
time allocated to support each clinic was low. The DCST cost varied slightly between the two
health districts; the cost in WR was $1 022.76 while in the DKK it was $1 221.63. The cost for
providing NIMART and PHC training for the nurses was significantly higher and accounted
for 20% ($4 868.60) of the additional annual cost.
Assisted self-management. Interviews with managers and a review of the reports of the
CHCW and WBOT staff members indicated that WBOTs/CHCW allocate 62% (SD: 43%) of
their time to adherence support and tracing defaulters on chronic medication. The mean num-
ber of WBOT/CHCW per facility was 21 (SD:20) (Table 1), and each earns $242 72 per month.
The WBOTs and CHCW are supervised by nurses for a portion of their time at a mean of
mean 52% (SD:12%). In two of the PHC clinics, two professional nurses provided supervision
(clinic A and C) clinics and in the other two, four enrolled nurses provided this service (clinic
B and D). The estimated current mean annual cost of providing assisted self-management was
$60 995.85 (SD:$58,33) for WBOTs/CHCW and $30 208.42 (SD:1,063) for their supervision.
The costs per clinic for WBOTs/CHCW differed by clinic as it is greatly affected by the num-
ber of WBOTs/CHCW based at each clinic according to the number of community wards. For
example the cost for clinic C was $145 228.22 for 50 WBOTs/CHCW versus $11 618.25 in
clinic A for 4 WBOTs/CHCW. The additional cost of providing adherence clubs for assisted
self-management varied from $3 507.47 in a clinic with 981 patients with chronic disease con-
sultations per month (Clinic A) to $10 477.32 in a clinic with almost 3000 patients per month
(Clinic C).
Table 3. Mean current and additional annual costs of implementing the recommended activities for ICDM model per PHC clinic.
ICDM Model Component Items Estimated annual costs Mean (SD) Proportion of costs
Current Costs Facility reorganization Building $23 748.74 (19 478) 19.1%
Furniture $1 704.02 (343) 1.4%
Equipment $611.87 (231) 0.5%
Building maintenance $5 957.16 (4 886) 4.8%
Clinical supportive management DCST $1 119.09 (115) 0.9%
Assisted self-management WBOT Supervision $30 208.42 (1 063) 24.3%
WBOT $60 995.85 (58 333) 49.1%
Total current costs $124 345.15 (60 776) 100%
Additional Costs Facility reorganization Building $8 346.12 (1 098) 34.6%
Furniture $890.65 (855) 3.7%
Equipment $431.87 (433) 1.8%
Building maintenance $2 093.55 (275) 8.7%
Clinical supportive management NIMART Training $2 679.81 (1 128) 11.1%
PHC Training $2 188.80 (928) 9.1%
Assisted self-management Adherence Club $7 470.80 (3 146) 31.0%
Total additional costs $24 101.60 (6 040) 100%
Current costs $124 345.15 85%
Additional costs $24 101.60 15%
Total mean costs of implementing ICDM model $148 446.75 (65 125) 100%
https://doi.org/10.1371/journal.pone.0235429.t003
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Sensitivity analysis. The key parameters in the cost model and the one-way sensitivity
analyses are outlined in Table 4 and Fig 1. The current building cost was $18 513.18 at discount
rate from 4% and $25 625.80 at 9%; while additional building cost was $6 506.17 and $9 005.79
for 4% and 9% discount rates. Based on the one-way sensitivity analysis, the major cost drivers
are the proportion of effort of the WBOTs/CHCW per WBOTs supervisor and the number of
patients accessing chronic disease care. Varying the building cost according to whether or not
additional consulting rooms are included also revealed that building is a major cost driver in
the additional cost (Fig 1B).
Discussion
From the provider’s perspective, we estimated that the annual mean cost of implementing the
ICDM model activities are $148 446.75 per clinic or $6.00 per patient with chronic disease per
visit. The current cost was the largest component of the overall ICDM model implementation
cost. The additional costs were lower for clinics with a higher degree of implementation fidel-
ity. Facility reorganization accounted for 49%, adherence clubs 31% and training of nursing
staff 20% of the additional mean cost. Assisted self-management was the most costly compo-
nent of the ICDM model to implement, and it contributed 73% of the current cost and 31% of
the additional cost. The overall ICDM model implementation cost varied between the four
study PHC clinics. The major cost drivers were the number of patients accessing services for
chronic disease management and associated WBOTs to support assisted self-management and
the required additional infrastructure.
The annual cost of implementing the ICDM model activities was $148,446.75 per clinic.
The cost of implementing a team-based chronic care model in another study conducted in
northern California, USA, was estimated at $2 304 787.00 over 29 months ($79 475.41 per
month) [36]. Chronic disease management, particularly in the context of multimorbidity, is
the largest expense for health systems [4–6]. More research and strategies to improve the effec-
tiveness of the ICDM model to enhance health outcomes for all chronic diseases are important
to support such an expenditure [18, 19]. A systematic review showed other types of integrated
care for chronic diseases, based on similar principles as the ICDM model to be cost-effective
by reducing health utilization and improving health outcomes [16]. All the studies that were
reviewed had been conducted in high-income countries [16]. In this study, the current cost
was the largest component of the total estimated mean annual cost of the ICDM model. This
Table 4. The range of key parameters in the costs model.




Building–proportion of patients with chronic diseases 59% 16% 43% -75%
Building maintenance–proportion of patients with chronic
diseases
59% 16% 43% -75%
WBOT supervison–effort on ICDM model activities 52% 12% 40%– 64%
WBOT–effort on ICDM model activities 62% 43% 18% -
100%
Additional costs
Building–including or excluding additional consulting rooms 3 N/A 0–3
Adherance club–number of patients with chronic diseases 2 090 880 1 210–2
970
NIMART training–number of nurses to be trained per annum 6 3 3–9
PHC training—number of nurses to be trained per annum 6 3 3–9
https://doi.org/10.1371/journal.pone.0235429.t004
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reflects the increased allocation of financial resources by the South African Department of
Health to PHC clinics to ensure that there is adequate infrastructure, medicines and supplies
at PHC clinics [32].
Fig 1. Torando diagram summarizing one-way sensitivity analyses of mean and cost of implementing the recommended activities of the
ICDM model per PHR clinic. Middle line = zero costs.
https://doi.org/10.1371/journal.pone.0235429.g001
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The major contributor to the additional cost was additional infrastructure required for
facility reorganization activities. These costs are lower than the cost of assisted self-manage-
ment and clinical supportive management. However, the expenditure requires capital invest-
ment for which the health system might not have an available allocated budget. Clinical
supportive management activities were the least costly, contributing 6% of the total cost. A
report from South Africa has revealed that chronic diseases (diabetes, hypertension, asthma
and epilepsy) are not adequately managed at PHC clinics, and there are few healthcare workers
with adequate and competent training [37]. Our study findings support the view that a rela-
tively low-cost investment in clinical supportive management can potentially have a high yield,
improving quality of care for patients with chronic diseases.
Assisted self-management was the most costly component of the ICDM model to imple-
ment, and contributed 73% of the current cost and 31% of the additional cost. There was a
great variability among clinics as some clinics were allocated more personnel. Human resource
cost was also the highest cost in a team-based chronic care model [36]. In a study in Poland,
the addition of integrated home-orientated services that included education and family sup-
port for patients with advanced chronic obstructive pulmonary disease (COPD) reduced the
overall cost of care from the health system perspective [38]. The main reasons for cost reduc-
tion were reduced hospitalizations and disease exacerbations [38]. However, in other studies,
the chronic care model reduced costs related to unplanned hospitalization, but increased costs
for out-patient consultations and medication [39, 40]. Community-based adherence support
and delivery of medication reduces the cost of accessing care from the patient’s perspective.
Cost has been mentioned as the greatest barrier to seeking care among 47% of patients in
South Africa [41]. Affordability is greatly affected by travel cost as many of the PHC clinics are
not within a walking distance of patients, especially in rural areas [42]. Despite the high cost of
assisted self-management, it is an important component of chronic disease management to
support adherence and reduce overcrowding at PHC clinics.
The cost of implementing the ICDM model activities varied across the four study PHC clin-
ics, and the major cost drivers were the number of patients with chronic diseases consulted, as
well as personnel for assisted self-management and the required additional infrastructure.
High building costs for large clinics also contributed to some of the variation in clinic costs. A
systematic review of chronic disease management programmes implemented in high-income
countries showed that 14/16 (88%) of the studies demonstrated cost-effectiveness based on
quality-adjusted life-year, while two studies had less than US$30 000 per life-year gained.
Some of the reasons for the differences in the outcomes include the components of the chronic
disease management programme that were implemented, the type of chronic disease being
treated and level of comprehensiveness in measuring the costs [43]. In another study on a dia-
betes quality improvement project in five clinics in the USA, the cost of providing chronic care
services per patient with diabetes per year varied from $6 in large clinics to $68 in small clinics
[44].
Strengths and limitations
The strength of this study is that it is one of the few studies that provides a cost analysis of
implementing a chronic disease management model in a middle-income country. Moreover,
most of the costs in the cost analysis are based on the actual costs for clinics to implement the
ICDM model recommended activities. The results of this cost analysis could also be used for
additional economic evaluations of the ICDM model. As data were collected from only four
PHC clinics, a limitation of the study is that this small sample size could have resulted in large
variability in the observed results. The generalizability of these results could also be limited by
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this small sample size. However, we minimized this by including clinics with different degrees
of implementation fidelity to the ICDM model from two different provinces. Therefore, this
data would be informative for budgeting and resource allocation for clinics with similar char-
acteristics. Another limitation of this analysis is that it does not include a full cost-effectiveness
analysis as there is limited data on the effectiveness of the ICDM model in South Africa. The
standard healthcare costs, like laboratory investigations, treatment of complications and medi-
cation was not included in the calculations and that leads to an underestimation of the overall
cost of providing care to patients with chronic diseases. Lastly, only three of the four compo-
nents of the ICDM model were included in the analysis. Therefore more research is needed on
the implementation costs of the ICDM model activities related to strengthening of support
systems.
Conclusion
The estimated mean cost of implementing the ICDM model activities was $6.00 per patient
with chronic disease per consultation. The greater portion of the costs are current costs. The
additional cost of implementing the ICDM model with higher fidelity was minimal and com-
prised mainly of costs for facility reorganization and training of personnel. The mean cost of
implementing the ICDM model activities varied between clinics and were affected by patient
case load and the required additional infrastructure. The results of this cost analysis can enable
additional ICDM model cost evaluations and budgetary planning for scale-up and scale-out of
the ICDM model or similar models in countries with a similar disease burden and resources.
Furthermore, this study provides information on the additional resources required to enhance
the fidelity to the implementation of the ICDM model. Further research is needed on the cost-
effectiveness of implementing the ICDM model for the management of patients with chronic
diseases in South Africa and other similar contexts, as most of the studies published on cost-
effectiveness of chronic care models are from high-income countries.
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